SEND – an opportunity for CROs to Enhance Competitiveness and Business Value

This webinar will present the business opportunity of delivering high quality SEND datasets guaranteed to pass through the NIMS gateway at the FDA while bringing improved efficiency to sponsor-CRO data specifications.  We will discuss how this can be done with minimal disruption to your existing business processes.

On December 17, 2014 the FDA issued a binding guidance requiring SEND compliance. In the future, few sponsors, if any, will deal with CROs that cannot provide a valid SEND dataset for the studies they conduct. CROs should embrace SEND as an opportunity to gain a competitive edge and enhance their revenues.

For more information, please contact: